U.S. Chemicals Stock News

Pacira BioSciences, Inc. recently reported first-quarter 2026 results showing revenue of US$177.38 million, up from US$168.92 million a year earlier, while net income eased to US$2.92 million and diluted EPS to US$0.07. Alongside these results, the company highlighted real-world Medicare data for EXPAREL showing reduced opioid use and medical costs after outpatient hip replacements, while an activist proxy battle with DOMA Perpetual Capital Management adds a governance twist ahead of the...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Hess...

It looks like First Bank ( NASDAQ:FRBA ) is about to go ex-dividend in the next four days. Typically, the ex-dividend...

Some First Financial Bancorp. ( NASDAQ:FFBC ) shareholders may be a little concerned to see that the Chairman of the...

Anyone interested in Pathward Financial, Inc. ( NASDAQ:CASH ) should probably be aware that the Independent Director...

We wouldn't blame Adobe Inc. ( NASDAQ:ADBE ) shareholders if they were a little worried about the fact that Shantanu...

Universal Insurance Holdings, Inc. ( NYSE:UVE ) is about to trade ex-dividend in the next four days. The ex-dividend...

Timken (NYSE:TKR) agreed to sell its belts business to Gates Industrial in a transaction expected to close in the third quarter. The deal is intended to sharpen Timken’s focus on core operations and support margin improvement in its Industrial Motion segment. Transaction proceeds are planned to fund Timken’s broader capital allocation priorities. For you as an investor, this move sits at the intersection of two industrial names that both operate across power transmission and motion control...

Wondering if Acadia Healthcare Company at around US$27.85 is a bargain or a value trap? This article walks through what the current price might be implying. The stock has returned 1.7% over the past week, 16.2% over the last month, 94.9% year to date and 19.5% over the past year, while the 3 year and 5 year returns of 59.7% and 56.5% declines show that longer term holders have had a very different experience. Recent coverage has focused on Acadia Healthcare Company as a specialist in...

Azenta has appointed Trey (William E.) Martin III as President of its Multiomics business, with former president Ginger Zhou remaining as an advisor through November 2026, and granted him 17,790 time-vested RSUs that will vest in equal annual tranches from April 2027 to April 2029. This leadership transition in a core growth area, coupled with equity-based incentives, signals how Azenta is aligning executive oversight and compensation with its long-range Multiomics ambitions. Next, we’ll...

Waste Connections (WCN) shares were in focus after first quarter 2026 results topped expectations, with management reaffirming full year guidance and pointing to benefits from solid waste pricing, special waste volumes, and AI driven pricing tools. See our latest analysis for Waste Connections. Despite the upbeat first quarter, the recent share price has been weaker, with a 30 day share price return of 2.92% and a year to date share price return of 7.40%. The 1 year total shareholder return...

Wondering if Sabra Health Care REIT at around US$20.36 is offering good value or if the easy money has already been made? This article walks through what the current price might be implying about the stock. Sabra's share price sits at US$20.36, with returns of 1.3% over 7 days, 2.5% over 30 days, 6.3% year to date and 24.7% over the past year, plus 127.5% over 3 years and 71.5% over 5 years. Recent news flow around Sabra has focused on its role as a health care focused REIT and how investors...

Equity Residential, NYSE:EQR, is reportedly in early talks with AvalonBay about a potential merger. The discussions involve two of the largest apartment REITs in the US and relate to combining their residential portfolios. If pursued, the deal could be one of the largest in US real estate, with implications for scale and operations across major apartment markets. For Equity Residential, the news comes with the shares at $65.17 and a mixed recent return profile. The stock is up 4.7% over the...

Wondering whether Smithfield Foods at US$26.29 is offering good value or asking too much? This article walks you through what the current share price actually reflects. Over the past week the stock has seen a 10.4% decline, although it remains up 18.7% year to date and 19.5% over the last year. These movements can change how you think about both opportunity and risk. Recent coverage has focused on how Smithfield Foods fits into broader shifts in the US food sector and what that might mean...

If you are wondering whether Watsco is priced attractively or already reflecting high expectations, the recent share performance gives you some useful clues before you dig into the valuation work. The stock closed at US$428.57, with a 2.7% pullback over the last week, a 15.7% gain over 30 days, a 23.4% return year to date, and a 6.4% decline over the past year. This mix can point to shifting views on both growth potential and risk. Recent attention around Watsco has focused on its position...

Everest Group, Ltd. reported past first-quarter 2026 earnings with revenue of US$4.07 billion, down from US$4.26 billion a year earlier, while net income rose to US$653 million and basic earnings per share from continuing operations increased to US$16.21. The quarter underscored Everest’s emphasis on profitability and capital efficiency, as improved underwriting performance and higher-margin business mix lifted earnings despite weaker top-line revenue. Next, we’ll examine how this...

If you are wondering whether EOG Resources at around US$138.95 is offering fair value or a potential bargain, it helps to start by lining up what the recent share price is telling you against a few simple valuation checks. The stock has returned 4.4% over the last 7 days, while the 30 day return sits at a 2.6% decline, and over longer periods it has returned 29.5% year to date, 29.8% over 1 year, 35.3% over 3 years, and 114.0% over 5 years. Recent coverage has focused on EOG Resources as a...

Investors may be wondering if Avis Budget Group at around US$185 per share still offers value after its big run, or if the easy money has already been made. The stock has pulled back with a 9.0% decline over the last week and a 2.6% decline over the last month, yet it still shows returns of 44.7% year to date and 92.9% over the past year. Recent coverage has focused on how the share price sits after strong multi year returns, and what that means for investors coming in now. Commentators have...

In the first quarter of 2026, AXIS Capital Holdings Limited reported revenue of US$1,643.63 million and net income of US$254.77 million, with earnings per share from continuing operations rising versus the same period a year earlier. Management credited the stronger results to disciplined underwriting, premium growth in short-tail and specialty lines, and efficiency gains from technology and AI-driven underwriting platforms, alongside continued capital return actions. Now we’ll explore how...

Darling Ingredients (NYSE:DAR) reported a fundamental turnaround in Q1 2026, returning to net profitability. Margins improved across both the core business and the Diamond Green Diesel joint venture. Management linked the shift to favorable regulation, tighter operations, and a more constructive outlook for earnings and cash flow. For investors following Darling Ingredients, the Q1 2026 results mark a clear reset in the story around NYSE:DAR. The share price sits at $63.77, with the stock...

PriceSmart, Inc. has released its Fiscal Year 2025 Sustainability Report, highlighting extensive solar power adoption across 48 of its 56 warehouse clubs and detailing plans, already announced and now underway, to open five additional clubs that would bring its network to 61 locations. The report also outlines the Women@PriceSmart program, signaling a stronger focus on workforce development and gender inclusion alongside the company’s physical expansion. We’ll now examine how PriceSmart’s...

If you are wondering whether Haemonetics at around US$59.26 is a bargain or just fairly priced right now, this article walks through what the numbers say about its value. The stock has seen mixed returns, with a 1.1% decline over the last 7 days, a 4.3% gain over 30 days, and year to date and 1 year returns of 25.9% and 7.2% declines. These movements may be prompting new questions about risk and opportunity. Recent news coverage has focused on Haemonetics as part of broader discussions...

In the first quarter of 2026, Iridium Communications Inc. reported revenue of US$219.06 million versus US$214.88 million a year earlier, while net income fell to US$21.59 million from US$30.41 million and diluted EPS from continuing operations eased to US$0.20 from US$0.27. Iridium also reiterated its 2026 outlook for total service revenue to be flat to 2%, signaling a cautious near-term growth profile despite higher quarterly sales. With Iridium reaffirming expectations for flat to slightly...

What Landstar’s latest quarter tells you Landstar System (LSTR) just released first quarter results, with sales of US$1,149.56 million and net income of US$39.44 million, and reported basic EPS from continuing operations of US$1.16. Management also highlighted heavy haul revenue, lower insurance and claims costs, AI-related initiatives, and a focus on U.S. Mexico cross border freight and carrier vetting, giving investors more context than the headline numbers alone. See our latest analysis...